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Abstract
The public's need for health and dietary adequacy has been the driving force for their use of 
Nutraceutical supplements. Moringa oleifera is one of the herbal plants promoted based on its 
acclaimed of its Nutraceutical benefits. However awareness and adoption are critical issues in the 
utilization of any product/service. This preliminary survey was conducted to examine the 
consumption of moringa products for nutraceutical benefits in Ilorin, Kwara state, Nigeria. One 
hundred adult respondents were interviewed using semi-structured questionnaire. Descriptive 
statistics, Binary Logistic Regression and non-parametric correlation analyses were employed to 
achieve the study's objectives. The results indicated that a fairly high proportion of the 
respondents (48%) had used Moringa products for its claimed Nutraceutical benefits. Lack of 
awareness was a major barrier to the use of Moringa product: 87% of the non-users indicated lack 
of awareness as a reason for non-use. Educating non-users on its claimed Nutraceutical benefits 
led to 85% prospective adoption. However, given knowledge, the major determinant of reticence 
to its adoption was safety concerns, which is statistically significant (p<0.01). Hence, it is 
recommended that an awareness of the claimed Nutraceutical benefits of Moringa products 
should be increased since it could increase adoption with a consequent increase in market share. 
However, it is paramount that pre-clinical and clinical trials on Moringa products for claimed 
Nutraceutical benefits should be conducted to assure its safety and efficacy in the immediate and 
long term. 
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INTRODUCTION
Moringa oleifera is one of the species of Moringa tree which is often referred to as “the miracle tree” 
(Wallis, 2003). The tree is native to India (Coote et al., 1997), but it is currently found in many parts 
of the world. In Nigeria, it is found in the Northern, Southern, Western and Eastern parts of the 
country. The plant is known as “Zogale” in Hausa, “Gawara”, in Fulani, “Okwe Oyibo” in Igbo, and 
“Ewe Igbale” in Yoruba (Kadashi, 2008).   
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Moringa oleifera has been adopted as a national plant and it is being cultivated as a crop due to 
many claimed benefits offered by the plant. The plant is claimed to have many nutraceutical 
benefits: antibacterial, anticancer, antiasthma, antihypertensive, immunity booster, anti-
inflammatory, improves fertility and reproductive health and nutritional supplement    
(Animashaun et al., 2013; Adejumo et al., 2012; Anwar et al., 2007; Fahey, 2005; Fuglie, 2000). 
Many scientific studies of the chemical profile of parts of the Moringa plant (Makkar and Becker, 
1996, 1997,  Goyal et al., 2007 and their examination in vitro and in animal models of human 
disease confirm that it is a rich source of micro- and macronutrients as well as several 
phytochemical compounds including antioxidant, anti-inflammatory, and antineoplastic 
compounds  ( Goyal et al., 2007) through which it may mediate its claimed effects in humans. 
Many studies in animals also confirm its low toxicity (Furo and Amballi, 2011) lending credence to 
claims that it is safety based on its use in human food and medicines for over two millennia.
The Nigerian Federal Government Raw Materials Research and Development Council 
(RMRDC), Nigeria, has been actively encouraging the uptake of Moringa oleifera farming and its 
consumption. Moreover, the public's concerns for health and dietary adequacy have been the 
driving force for the rapid growth of use of nutraceutical supplements. Hence, they turn to use of 
natural remedies or herbal products rather than orthodox medicines. Moringa oleifera is one of 
the natural products that have been used due to claimed Nutraceutical benefits.
However, one of the strategies for the adoption for use of any product/service is behaviour 
modification.  According to Hochbaum (1995), human behavior is in a paradigm with awareness 
at the beginning which affects knowledge with consequent effect on understanding. The 
understanding affects attitude which then affects habits which is at the end of the paradigm. Habit 
is the output of behaviour.  While bahaviour modification has to be voluntary, it can be motivated 
through information, education and communication. A user acceptance of any product/service at 
the individual level is associated with its perceived usefulness (Morton and Wiedenbeck, 2009; 
Archer and Cocosila, 2011). Hence, implementing an intervention such as the exposure of the 
populace to the usefulness of the product/service could affect positively the willingness to adopt 
the use of it.
A survey of the awareness, usage and perception of food supplements among adult residents in 
Metro Manila in 2008 when compared to an earlier study in 1998 revealed an increase in the 
awareness and usage of the food supplement from 37.5% to 85.6% and 22.9% to 46.8% 
respectively (Cruz et al., 2011). Such increasing awareness is not surprising since many of the 
orthodox medicines used in the prevention and treatment of diseases today originate from plants 
(Federal Ministry of Health, Nigeria, 2005). For example digoxin a glycoside used in congestive 
heart failure is from leaves of Digitalis lanata. Quinine an antimalarial and quinidine an 
antiarrythmia are alkaloids found in cinchona bark. Despite many of these supplements 
appearing to be safe, some of the commonly used herbal supplements have shown severe side 
effects and interactions with orthodox medicines or other herbal supplements. In some cases, 
several deaths have occurred such as that caused by ephedra occasioning its ban by United 
States Food and Drug Administration in 2003. Liver toxicity from pyrrolidine alkaloids found in 
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some plants, nephrotoxicty induced by aristolochia (Chinese herb) and cardiac events associated 
with ephedra alkaloids are a few examples (Society of Gastroenterology Nurses and Associates 
Inc. 2012). Examples of herbal supplements interacting with orthodox medicines include St. 
John's wort (an antidepressant) reducing the plasma concentrations of digoxin (a digitalis used for 
congestive heart failure) and indinavir (antiretroviral medicine) and garlic, ginger and ginkgo 
biloba increasing the antiplatelet activities of ibuprofen, aspirin and warfarin (Lacy et al., 2006). 
Hence, the requirement of the Nigerian National Drug Policy that there should be an investigation 
into herbal medicines for efficacy, safety and quality with a view to integrating them into the 
healthcare system (Federal Ministry of Health, Nigeria, 2005). According to the Nigerian National 
Drug Policy, this is one of the areas listed for research that should be supported with provision of 
grants by the Government, local and International development parties. This study was therefore 
aimed at investigating the consumption of moringa products for nutraceutical benefits in Ilorin, 
Kwara state, Nigeria.
The objectives of the study were to:
I     assess the usage of Moringa product for claimed nutraceutical benefits;
II examine the respondents' willingness to adopt Moringa product for claimed 
nutraceutical benefits;
III identify the perceived constraints to the use of Moringa for claimed nutraceutical 
benefits and
IV explore the respondents' preferred and alternative choices of the form of presentation 
of Moringa products for nutraceutical benefits.
MATERIALS AND METHODS
The study is a descriptive preliminary survey of the consumption of moringa products for 
nutraceutical benefits in Ilorin, Kwara State, Nigeria. One hundred adult respondents were 
purposively sampled and interviewed using semi-structured questionnaires. The questionnaires 
were designed to collect information on respondents' demographic characteristics, use of 
Moringa products for claimed nutraceutical benefits, willingness to adopt the use of Moringa 
product for claimed nutraceutical benefits and the preference of choice of the form of presentation 
of Moringa products.
The data obtained was stored on a computer and analyzed using Statistical Package for Social 
Sciences (SPSS) version 17 computer software. Descriptive statistics, binary logistic regression 
and non-parametric correlation analyses were employed to achieve the study's objectives.  
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RESULTS
Table 1: Socio-demographic characteristics of respondents.
SOCIO-DEMOGRAPHIC CHARACTERISTICS FREQUENCY PERCENTAGE
A.   GENDER
                    Male 69 69
                    Female           31  31
B.   EDUCATION
                     No formal education 1 1
        Qur'anic school 1 1
                      Primary school 8 8
         Secondary school 38 38
                      Tertiary school 52 52
                      Total 100 100
C. AGE IN YEARS
                       18 -27            20 20
                        28  37 42 42
                       38  47 19 19
                       48 - 57                                        14 14
                       58 - 67 4 4
> 68 1 1
                       Total 100 100
D. OCCUPATION
                      Artisan 7 7
                      Farmer 2 2
                      Trader     8 8
                      Private service        38 38
                      Public service           45 45
                     Total 100 100
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Figure 1: Distribution of respondents according to the use of moringa products
Figure 2: Reasons for the non-usage of moringa products.
169 
Willams, Animashaun, Ibrahim & Toye
Figure 3: Distribution of the non-users according to willingness to use after 
being exposed to the claimed Nutraceutical benefits of Moringa products.  
Table 2: Determinants of reticence to the adoption of Moringa product for 
claimed Nutraceutical benefits.
Variables Coefficient Standard 
error 
  p 95% confidence 
interval 
Gender (male) 0.8366445 0.9334602 0.37 -0.9929 2.6661 
Education attained 0.54249 0.54703 0.32 -0.52967 1.6146 
Age 0.01717 0.04611 0.71 0.0732 0.1075 
Occupational 
activities 
-1.4761 1.017307 0.14 -3.4700 0.5177 
Safety concerns -37.63525 1.417359 0.00*** -40.4132 -34.857 
Availability 18.0564 - - - - 
Constant 6.158346 5.5889 0.27 -4.7958 17.1125 
LogLikelihood= -
17.86 
LR chi2= 24.19 
P>chi2=0.01 
Pseudo R2 =0.4037  
     
 *** Indicates p-value significance at 1 %
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FREQUENCY PERCENTAGE FREQUENCY PERCENTAGE 
Teabag 60 60 40 40 
Juice 34 34 66 66 
Confectionary 24 24 76 76 
Dry powder 39 39 61 61 
Capsule 32 32 68 68 
Snack 17 17 83 83 
Tablet  43 43 57 57 
Liquid extract 31 31 69 69 
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1      
Dry powder 0.318** 0.422*
* 
0.415** 1     
Capsule 0.473** 0.458 0.669** 0.550** 1    
Snacks 0.206* 0.293 0.369** 0.239* 0.546** 1   
Tablets  0.297** 0.315 0.411** 0.465** 0.617** 0.252* 1  
Liquid 
extracts 
0.371** 0.477 0.535** 0.351** 0.560** 0.272 0.422** 1 
 Note: Single asterisks indicate significance of Correlation at p<0.05.
           Double asterisks indicate significance of Correlation at p<0.01
DISCUSSION
The socio-demographic characteristics of the respondents showed that 69% were male while 
52% had tertiary education (Table 1). The age range was 20 years to 78 years with a modal age 
class of 28-37 years (Table 1). Forty five percent of the respondents were in the public service 
while 2% were farmers. There is relative bias with regards to the gender of the respondents. 
The Users of moringa products constitute about half of the study population (48%) as shown in 
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Figure 1. This is slightly higher than the findings of the study conducted by Cruz et al., (2011) 
where 46.8% were users of food supplements. This contrast may be underpinned by the 
increasing concerns about health and dietary adequacy and increasing exposure to the claimed 
health benefits of Moringa in Nigeria. Indeed, the data suggests that there is still room for growth 
in the use of Moringa in the study population given that lack of awareness accounted for 87% of 
the reasons for the non-usage (Figure 2). This finding is different from the finding of an earlier 
study in which the major barrier to the use of food supplement was “very expensive” (high cost) 
which accounted for 58.8% of the respondents (Cruz et al., 2011). The shift in reason for the 
non-usage of Moringa products could be due to the increase in concerns for health and dietary 
adequacy such that respondents were more willing to pay for any product/service that they 
perceive would meet these concerns.  
Exposing the non-users in the present study population to the claimed Nutraceutical benefits of 
Moringa products resulted in 85% prospective adoption. This is in line with Hochbaum's 
bahaviour paradigm in which awareness affects knowledge with consequent effect on attitude 
(Hochbaum, 1995), which is manifested in the individual's willingness to use moringa products. 
This prospective adoption could be due to the perception of usefulness of Moringa product in 
line with the studies conducted by Morton and Wiedenbeck, (2009) and Archer and Cocosila 
(2011) which showed that awareness about the perceived usefulness of a product/service 
affects its adoption. Thus creating awareness about the Nutraceutical benefits of Moringa could 
lead to an increase in the consumption with a consequent increase in the market share. The 
economic implications of this are that increased market share would lead to job and wealth 
evaluation for the individuals and the nation. This will contribute to the achievement of 
Millennium Development Goal (MDG) number 1: Eradication of extreme poverty and hunger.                                
Despite the exposure of the non-users of Moringa products to the Nutraceutical benefits, about 
one-eighth of the respondents indicated their non-willingness to use it. The major determinant 
of reticence was safety concerns which is statistically significant (p<0.01) as shown in Table 2. 
This is expected in view of the adverse drug reactions and drug interactions observed in the use 
of herbal supplements such as ginger, garlic and ginkobiloba with ibuprofen, warfarin and 
aspirin; and St John's wort with antiretroviral protease inhibitors (Lacy, 2006). There were also 
cases of toxicity of ephedra alkaloids. Hence, it is necessary to conduct pre-clinical and clinical 
tests on the Moringa products in order to assure its safety and efficacy in the short and long term 
in line with the requirements of Nigerian National Drug Policy (2006). There is also the need for 
standardization of Moringa products and formulations with a view to integrating such products 
into the healthcare system.
With reference to the preferred choice of the form of the presentation of Moringa products, 
three-fifth of the respondents preferred the tea bag Table 3. This is expected since individuals 
have been observed to consume herbal tea as regular users once or 2-3 times daily or as 
sporadic users once or 2-3 times daily (Cruz et al., 2011). This could also be due to social 
signaling value of tea consumption.  
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The respondents' preferred alternative choices of the form of presentation showed that 
respondents who preferred tablet would more likely prefer capsule (r = 0.617; p< 0.01) as shown 
in Table 4. This may be due to ease of handling and/or the perception of similarity of forms: both 
are medicine dosage forms. However, respondents who preferred confectionary were more likely 
to prefer capsule forms of presentation (r = 0.669; p< 0.01), while respondents who preferred 
snacks were more likely to prefer capsule forms; of presentation (r = 0.546; p< 0.01). The latter 
two alternative choices defy easy explanation and there is the need to conduct further studies with 
regards to the reasons for the alternative choices of the form of presentation.
The results of this study must be taken with caution, given the limitations of power afforded by the 
sample size of the respondents.
CONCLUSION AND RECOMMENDATIONS
Moringa products are used by about half of the study population and lack of awareness about the 
claimed nutraceutical benefits of Moringa products was a major reason for the non-usage (in the 
non-user population). Educating the non-users about the claimed nutraceutical benefits resulted 
in willingness to use products in a majority of cases. However reticence was found to persist in 
some non-users even after the education. The major determinant of reticence is safety concerns. 
Hence, it is necessary to conduct clinical tests to evaluate safety and efficacy in the immediate 
and long term. There should be standardization of the Moringa products and formulations with a 
view to integrating them into the healthcare system. Further studies are required with regards to 
the reasons for the alternative choices of the form of presentation identified in this study. This 
preliminary survey on the consumption of moringa products for nutraceutical benefits in Ilorin, 
Kwara State, Nigeria is limited with regards to sample size. Hence, further studies which are 
larger in scale are required so that findings can be extended to an adequately powered wider 
sample of the population and independently evaluated. Perception, attitudes, use and 
Nutraceutical efficacy of Moringa among children and the elderly were purposely omitted from the 
current study and should be examined independently.
This study recommended that:
I government and other Stakeholders should create more awareness about the claimed 
nutraceutical benefits of Moringa products;
II government regulatory agencies should ensure that pre-clinical and clinical tests are conducted  
on Moringa products to define their safety and efficacy in the immediate and long term; 
III further studies should be conducted by researchers on the preferred and alternative choices of 
the form of presentation;
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IV government regulatory agencies should ensure standardization of Moringa products and 
formulations; and
V further studies which are larger in scale, and of adequate power, should be conducted by 
researchers so that findings can be evaluated in a wider population.
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